… -9.9 is useful in distinguishing between endometriomas and ovarian cancer, and its
combination with CA-125 is useful in differentiating endometrioma from other ovarian lesions. …

… females, 15 IU/l [20], or when HE4 was combined with CA125, … of serum CA125 levels
between endometrial cancer and … specificity of CA 125 for detecting endometrial cancer to only …

… biomarker to predict the recurrence of endometrial carcinoma (EC). We … ) and cancer antigen
125 (CA125) as the biomarkers to predict and monitor recurrence of type II EC. 191 patients …

… Furthermore, mesothelin has a strong affinity to cancer antigen 125 (CA125) … 3 endometrioid
carcinoma, serous carcinoma, clear cell carcinoma, carcinosarcoma, and mixed carcinoma …

… differences in the peripheral blood cells and tumor biomarkers between the patients with
endometriosis and healthy people, and establish a more efficient combined diagnostic model. …

… Cancer antigen 125 (CA125) and human epididymis protein 4 (HE4) have been reported in
endometrial cancer patients … evidence that preoperative serum CA125 combined with HE4 is …

… mixed Müllerian tumor, and endometrial stromal sarcoma were detected in 7 (5.3%), 4 (3.1%),
1 (0.8%), 3 (2.3%), and 1 (0.8%) patients, … CA 125 tumour marker in endometrial cancer: …

… The prognosis of early endometrial cancer patients is generally good, with a 5-year survival
… is poor for patients with high-risk endometrial cancer (Grade 3 or non-endometrioid histotype …

… 2), moderate (Stage 3) and severe (Stage 4) endometriosis, respectively. Considering
ultrasonography-negative and positive endometriosis groups together, we classified the women …

… diagnosis and identification of ovarian clear cell carcinoma (CCC) and ovarian endometrioid
carcinoma (EC), we evaluated CT imaging findings and cut-off values for CEA and CA125. …